This is an early step toward developing therapies for
metastasized cancers, MU scientist says
Cancers of all types become most deadly when they
metastasize and spread tumors throughout the body. Once cancer has reached this
stage, it becomes very difficult for doctors to locate and treat the numerous
tumors that can develop. Now, researchers at the University of Missouri have
found a way to create radioactive nanoparticles that target lymphoma tumor
cells wherever they may be in the body. Michael Lewis, an associate professor
of oncology in the MU College of Veterinary Medicine, says being able to target
secondary tumors is vital to successfully treating patients with progressive
cancers.